NCT00740753View on ClinicalTrials.gov

Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option

NACompletedINTERVENTIONAL
Enrollment

339

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

April 28, 2021

Study Completion Date

April 28, 2021

Conditions
Liver CancerHepatoma
Interventions
DEVICE

Yttrium 90 (TheraSphere)

Y-90 embedded glass microspheres

Sponsors
All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

collaborator

Boston Scientific Corporation

INDUSTRY

lead

OHSU Knight Cancer Institute

OTHER

NCT00740753 - Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option | Biotech Hunter | Biotech Hunter